ADMPT and its synthesis

Title: ADMPT and its synthesis

Full Record
Other Related Research

Abstract

3-Amino-6-(3,5-dimethylpyrazol-1-yl)-1,2,4,5-tetrazine (ADMPT) and a method of making it.

Inventors:

Coburn, Michael D ^[1]; Ott, Donald G ^[1]

Los Alamos, NM

Issue Date:: 1993-01-01

Research Org.:: Los Alamos National Lab. (LANL), Los Alamos, NM (United States)

OSTI Identifier:: 869100

Patent Number(s):: 5274091

Assignee:: United States of America as represented by United States (Washington, DC)

Patent Classifications (CPCs):: C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07D - HETEROCYCLIC COMPOUNDS

Show more

C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07D - HETEROCYCLIC COMPOUNDS
C07D231/12 - with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D249/08 - 1,2,4-Triazoles
C07D233/56 - with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Show less

DOE Contract Number:: W-7405-ENG-36

Resource Type:: Patent

Country of Publication:: United States

Language:: English

Subject:: admpt; synthesis; 3-amino-6-35-dimethylpyrazol-1-yl-1245-tetrazine; method; /999/

Citation Formats


                    Coburn, Michael D, and Ott, Donald G. ADMPT and its synthesis.  United States: N. p., 1993. 
        Web.

Copy to clipboard


                    Coburn, Michael D, & Ott, Donald G. ADMPT and its synthesis.  United States.

Copy to clipboard


                    Coburn, Michael D, and Ott, Donald G. Fri .  
        "ADMPT and its synthesis".  United States.  https://www.osti.gov/servlets/purl/869100.

Copy to clipboard


                    
@article{osti_869100,

  title        = {ADMPT and its synthesis},

  author       = {Coburn, Michael D and Ott, Donald G},

  abstractNote = {3-Amino-6-(3,5-dimethylpyrazol-1-yl)-1,2,4,5-tetrazine (ADMPT) and a method of making it.},

  doi          = {},

  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {1993},

  month        = {1}

}

Copy to clipboard

Patent:

View Patent

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE Patents and OSTI.GOV collections:

Synthesis of N-formyl-3,4-di-t-butoxycarbonyloxy-6-(trimethylstannyl)-L-phenylalanine ethyl ester and its regioselective radiofluorodestannylation to 6- .sup.18 F!fluoro-1-dopa

Patent Satyamurthy, Nagichettiar [Los Angeles, CA]; Barrio, Jorge R [Agoura Hills, CA]; Bishop, Allyson J [Wahnemuhle, DE]; ...

A process for forming a 6-fluoro derivative of compounds in the L-Dopa family comprising the steps of protecting the groups attached to the benzene ring in the compound followed by serially reacting the protected compound with (a) iodine and silver trifluoroacetic acid; (b) Bb.sub.3 ; (c) dit-butyldicarbonate; (d) hexamethyltin; (e) a fluoro compound; (f) hydrobromic acid; and (g) raising the pH to .ltoreq.7.
Full Text Available
Synthesis of N-formyl-3,4-di-t-butoxycarbonyloxy-6-(trimethylstannyl)-L-phenylalanine ethyl ester and its regioselective radiofluorodestannylation to 6-[.sup.18 F]fluoro-L-dopa

Patent Satyamurthy, Nagichettiar [1613 Barry Ave. - Apt. #9, Los Angeles, CA 90025]; Barrio, Jorge R [5920 Grey Rock Rd., Agoura Hills, CA 91301]; Bishop, Allyson J [1661 Selby Ave. - Apt. 5A, Los Angeles, CA 90024]; ...

A protected 6-trimethylstannyl dopa derivative has been synthesized for the as a precursor for the preparation of 6-[.sup.18 F]fluoro-L-dopa. The tin derivative readily reacts with electrophilic radiofluorinating agents such as [.sup.18 F]F.sub.2, [.sup.18 F]OF.sub.2 and [.sup.18 F]AcOF. The [.sup.18 F]fluoro intermediate was easily hydrolyzed with HBr and the product 6-[.sup.18 F]fluoro-L-dopa was isolated after HPLC purification in a maximum radiochemical yield of 23%, ready for human use.
Full Text Available
Thiophene fused azacoronenes: regioselective synthesis, self organization, charge transport, and its incorporation in conjugated polymers

Patent Liu, Yi; He, Bo

A regioselective synthesis of an azacoronene fused with two peripheral thiophene groups has been realized through a concise synthetic route. The resulting thienoazacoronene (TAC) derivatives show high degree of self-organization in solution, in single crystals, in the bulk, and in spuncast thin films. Spuncast thin film field-effect transistors of the TACs exhibited mobilities up to 0.028 cm.sup.2V.sup.-1 S.sup.-1, which is among the top field effect mobilities for solution processed discotic materials. Organic photovoltaic devices using TAC-containing conjugated polymers as the donor material exhibited a high open-circuit voltage of 0.89 V, which was ascribable to TAC's low-lying highest occupied molecular orbitalmore » energy level.« less
Full Text Available
Methanol synthesis using a catalyst combination of alkali or alkaline earth salts and reduced copper chromite for methanol synthesis

Patent Tierney, John W [Pittsburgh, PA]; Wender, Irving [Pittsburgh, PA]; Palekar, Vishwesh M [Pittsburgh, PA]

The present invention relates to a novel route for the synthesis of methanol, and more specifically to the production of methanol by contacting synthesis gas under relatively mild conditions in a slurry phase with a catalyst combination comprising reduced copper chromite and basic alkali salts or alkaline earth salts. The present invention allows the synthesis of methanol to occur in the temperature range of approximately 100.degree.-160.degree. C. and the pressure range of 40-65 atm. The process produces methanol with up to 90% syngas conversion per pass and up to 95% methanol selectivity. The only major by-product is a small amountmore »« less
Full Text Available
Human dopamine receptor and its uses

Patent Civelli, Olivier [Portland, OR]; Van Tol, Hubert Henri-Marie [Toronto, CA]

The present invention is directed toward the isolation, characterization and pharmacological use of the human D4 dopamine receptor. The nucleotide sequence of the gene corresponding to this receptor and alleleic variant thereof are provided by the invention. The invention also includes recombinant eukaryotic expression constructs capable of expressing the human D4 dopamine receptor in cultures of transformed eukaryotic cells. The invention provides cultures of transformed eukaryotic cells which synthesize the human D4 dopamine receptor, and methods for characterizing novel psychotropic compounds using such cultures.
Full Text Available

Similar Records